Fidelity Investments
SQZ

Fidelity Investments’s SQZ Biotechnologies Company SQZ Stock Holding History

Fidelity Investments’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-209
Closed -$1K – 5555
2022
Q2 		$1K Sell
209
-55
-21% -$198 ﹤0.01% 4844
2022
Q1 		$1K Buy
+264
New +$1.68K ﹤0.01% 4883

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments's SQZ Position: Q3 2022 in Review

Fidelity Investments sold out of SQZ Biotechnologies Company (SQZ) in Q3 2022, closing a stake of 209 shares — an estimated $1K sold.

Fidelity Investments first reported a position in SQZ in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • Fidelity Investments reported no remaining SQZ Biotechnologies Company position as of Q3 2022 after selling out during the quarter.
  • Fidelity Investments sold 209 SQZ Biotechnologies Company shares in Q3 2022, an estimated $1K.
  • Fidelity Investments first reported a position in SQZ Biotechnologies Company in Q1 2022 and held it in 2 quarters.
  • Fidelity Investments's SQZ Biotechnologies Company position peaked at $1K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.